Literature DB >> 4329003

Energy metabolism in human erythrocytes. I. Effects of sodium fluoride.

S A Feig, S B Shohet, D G Nathan.   

Abstract

Exposure of red cells to fluoride produces a variety of metabolic alterations, most of which are based upon the secondary effects of enolase inhibition, which reduces pyruvate synthesis and interferes with the regeneration of diphosphopyridine nucleotide (NAD). Adenosine triphosphate (ATP) is consumed in the hexokinase and phosphofructokinase reactions but is not regenerated since the deficiency of NAD limits glyceraldehyde phosphate dehydrogenase. ATP depletion in the presence of fluoride and calcium induces a massive loss of cations and water. Of the other known sites of ATP utilization, membrane-bound ATPase is inhibited by fluoride, but the incorporation of fatty acids into membrane phospholipids is unaffected until ATP is depleted. The addition of methylene blue to fluoride-treated red cells regenerates NAD, permitting triose oxidation and the generation of 3-phosphoglycerate and 2,3-diphosphoglycerate. Enolase inhibition is then partially overcome by mass action, and sufficient glycolysis proceeds to maintain the concentration of ATP. This in turn prevents the massive cation and water loss, and permits membrane phospholipid renewal to proceed. Membrane ATPase activity is not restored by the oxidant so that normal cation leakage remains unopposed by cation pumping in red cells exposed to the combination of fluoride and methylene blue.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4329003      PMCID: PMC442073          DOI: 10.1172/JCI106662

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  INCORPORATION OF FATTY ACIDS INTO PHOSPHOLIPIDS OF ERYTHROCYTE MEMBRANES.

Authors:  M M OLIVEIRA; M VAUGHAN
Journal:  J Lipid Res       Date:  1964-04       Impact factor: 5.922

2.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

3.  The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

Authors:  J T DODGE; C MITCHELL; D J HANAHAN
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

4.  The role of calcium in the potassium permeability of human erythrocytes.

Authors:  G GARDOS
Journal:  Acta Physiol Acad Sci Hung       Date:  1959

5.  The function of calcium in the potassium permeability of human erythrocytes.

Authors:  G GARDOS
Journal:  Biochim Biophys Acta       Date:  1958-12

6.  Effect of ethylenediaminetetraacetate on the permeability of human erythrocytes.

Authors:  G GARDOS
Journal:  Acta Physiol Acad Sci Hung       Date:  1958

7.  Influence of glycolysis on NADH content in human erythrocytes.

Authors:  A Omachi; C B Scott; T E Parry
Journal:  Am J Physiol       Date:  1969-03

Review 8.  Pyruvate kinase deficiency and related disorders of red cell glycolysis.

Authors:  A S Keitt
Journal:  Am J Med       Date:  1966-11       Impact factor: 4.965

9.  Membrane adenosine triphosphatase as a participant in the active transport of sodium and potassium in the human erythrocyte.

Authors:  R L POST; C R MERRITT; C R KINSOLVING; C D ALBRIGHT
Journal:  J Biol Chem       Date:  1960-06       Impact factor: 5.157

10.  [The role of adenosine-triphosphoric acid (ATP) in the potassium permeability of human erythrocytes].

Authors:  G GARDOS; F B STRAUB
Journal:  Acta Physiol Acad Sci Hung       Date:  1957
View more
  12 in total

1.  Direct Cytoskeleton Forces Cause Membrane Softening in Red Blood Cells.

Authors:  Ruddi Rodríguez-García; Iván López-Montero; Michael Mell; Gustavo Egea; Nir S Gov; Francisco Monroy
Journal:  Biophys J       Date:  2015-06-16       Impact factor: 4.033

2.  Nitrate and Phosphate Transporters Rescue Fluoride Toxicity in Yeast.

Authors:  Nichole R Johnston; Scott A Strobel
Journal:  Chem Res Toxicol       Date:  2019-10-16       Impact factor: 3.739

3.  Influence of cyclandelate on in vitro red blood cell deformability.

Authors:  D W Hall; W E van den Hoven
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth.

Authors:  Taro Hitosugi; Lu Zhou; Shannon Elf; Jun Fan; Hee-Bum Kang; Jae Ho Seo; Changliang Shan; Qing Dai; Liang Zhang; Jianxin Xie; Ting-Lei Gu; Peng Jin; Masa Alečković; Gary LeRoy; Yibin Kang; Jessica A Sudderth; Ralph J DeBerardinis; Chi-Hao Luan; Georgia Z Chen; Susan Muller; Dong M Shin; Taofeek K Owonikoko; Sagar Lonial; Martha L Arellano; Hanna J Khoury; Fadlo R Khuri; Benjamin H Lee; Keqiang Ye; Titus J Boggon; Sumin Kang; Chuan He; Jing Chen
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

5.  Further studies of sodium transport in feline red cells.

Authors:  R I Sha'afi; E Pascoe
Journal:  J Gen Physiol       Date:  1973-06       Impact factor: 4.086

6.  Energy metabolism in human erythrocytes. II. Effects of glucose depletion.

Authors:  S A Feig; G B Segel; S B Shohet; D G Nathan
Journal:  J Clin Invest       Date:  1972-06       Impact factor: 14.808

7.  Glucokinase activity in isolated islets from obese fa/fa Zucker rats.

Authors:  C B Chan
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

8.  Membrane flickering of the human erythrocyte: physical and chemical effectors.

Authors:  Max Puckeridge; Bogdan E Chapman; Arthur D Conigrave; Philip W Kuchel
Journal:  Eur Biophys J       Date:  2014-03-26       Impact factor: 1.733

Review 9.  Principles of fluoride toxicity and the cellular response: a review.

Authors:  Nichole R Johnston; Scott A Strobel
Journal:  Arch Toxicol       Date:  2020-03-09       Impact factor: 5.153

10.  The role of oxidized nicotinamide adenine dinucleotide in fluoride inhibition of active sodium transport in human erythrocytes.

Authors:  M S Millman; A Omachi
Journal:  J Gen Physiol       Date:  1972-09       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.